Saturday, December 28, 2013 5:46:37 PM
We're looking at the new Monsanto with virtually a global monopoly on seed/food production. A chemist I worked with in the late 90's owned old Monsanto at 2 bucks (before the new Monsanto IPO in 2000). They have a storied past, FDA, political and elite ties. Monsanto MTC (old) merged with Upjohn Pharmacia who eventually merged with Pfizer. Pharmacia spun off new Monsanto before the Pfizer deal. New Mon has a stock split in there somewhere (2006 I believe) and I know my chemist friend is now a multi millionaire buying and holding old/new Mon when they were just into herbicides and pesticides. Will XXII grow global tentacles and ties similar to the Monsanto beast?
Recent XXII News
- 22nd Century Group (Nasdaq: XXII) Launches Pinnacle VLN® Trial in California, Opening Another Major New State for Reduced-Nicotine Cigarettes • GlobeNewswire Inc. • 05/21/2026 11:00:00 AM
- 22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. Retailers • GlobeNewswire Inc. • 05/18/2026 01:00:00 PM
- 22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand • GlobeNewswire Inc. • 05/15/2026 12:37:00 PM
- 22nd Century Group, Inc. Highlights FDA Filing of VLN® MRTP Renewal Applications for Scientific Review • GlobeNewswire Inc. • 05/12/2026 05:50:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 10:30:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:06:10 AM
- 22nd Century Group Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 10:00:00 AM
- 22nd Century Group to Announce First Quarter 2026 Results on May 7, 2026 • GlobeNewswire Inc. • 05/04/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:20:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/01/2026 09:15:15 PM
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership • GlobeNewswire Inc. • 04/29/2026 08:35:00 PM
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University • GlobeNewswire Inc. • 04/23/2026 11:50:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:24 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:35:13 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:30:36 PM
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 09:00:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:02:51 PM
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 05:57:09 PM
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:14:20 PM
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products • GlobeNewswire Inc. • 02/23/2026 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:15:28 PM
